EU lays out path to dissolve Illumina/Grail

The European Commission has ordered Illumina and Grail to comply with a package of divestment and transitional measures as they unwind their deal to restore competition and continue the “innovation race” for early cancer detection tests.

Unlock unlimited access to all Global Competition Review content